Company: ARTL
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001640334-25-001429
Chunk: 402

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 402
---
 and the shares issuable upon such Warrants, the “Warrant Shares.” 

 13Table of Contents

Each Share or, at the election of the Purchaser in lieu of Shares, each Pre-Funded Warrant, was issued and sold along with two (2) $5.82 Warrants and one (1) $10.00 Warrant. The combined purchase price for the securities was (i) $6.195 per Share of Common Stock and three accompanying Warrants and (ii) $6.194 per Pre-Funded Warrant and three accompanying Warrants. The Private Placement closed on June 26, 2025 (the “Closing Date”).  Total gross proceeds were $1,425, net proceeds were $1,079 after transaction costs of $346.  Warrants A summary of activity of the warrants during the six months ended June 30, 2025, is as follows:         Weighted   Number of  Weighted Average  Average   shares  Exercise Price  Life (years) Outstanding, December 31, 2024  23,315  $67.50   0.79 Granted  783,249   6.36   5.00 Expired  -   -   - Exercised  -   -   - Outstanding, June 30, 2025  806,564  $8.12   4.85  The intrinsic value of the warrants as of June 30, 2025, is $5,416. All of the outstanding warrants are exercisable as of June 30, 2025. 2018 Equity Incentive Plan, as amended On February 28, 2025, the number of shares available under the Company’s 2018 Equity Incentive Plan, as amended (the “2018 Plan”) was increased by 80,693 shares of Common Stock. As of June 30, 2025, the 2018 Plan permits the Company to issue up to an aggregate of 335,564 shares of Common Stock of which 206,588 shares are available to be issued. The following is a summary of stock option activity during the six months ended June 30, 2025:   Options Outstanding  Weighted Average   Number of  Weighted Average  Remaining life   Options